ChemoCentryx Announces Financial Results for the Quarter Ended March 31, 2013

"Our progress this quarter was significant on several fronts, including advances in recruiting in our clinical trials," said Thomas J. Schall, Ph.D., President and Chief Executive Officer, ChemoCentryx.

http://www.globenewswire.com/news-release/2013/05/13/546713/10032608/en/ChemoCentryx-Announces-Financial-Results-for-the-Quarter-Ended-March-31-2013.html